Automation and Control System Market in Pharmaceutical and Biotech Industry: Global Industry Analysis and Forecast to 2020


Automation Control System  Market
  • To Be Published : Dec-2020 |
  • Status : Work in progress |
  • Format : Automation Control System  Market Automation Control System  Market Automation Control System  Market Automation Control System  Market

Automation and control system is integration of IT technology with mechanical systems. These systems are used for reliable and standardize production system. Reductions of waste, effortlessness monitoring and packaging and speed production are some of the advantages of automated and control system. In automation various devices and instruments are attached with IT systems for improved results in automation. It is offering customers with improved quality with standardization and dependable products within the time and at inexpensive cost. Several steps are necessary for new production and development of active pharmaceutical ingredient products. In addition, production requirements in pharmaceutical industry are increasing day by day. In pharmaceutical and biotech industry automation and control systems are mainly used for manufacturing and packaging, to provide high product quality. It also helps the pharmaceutical and biotech industry by saving energy and improving efficiency in manufacturing and packaging.

North America dominates the global market for automation and control system in pharmaceutical and biotech industry due to large number of aging population and accelerates investment in the industry. Asia followed by the Europe are expected to show high growth rates in the next five years in the global automation and control system market in pharmaceutical and biotech industry. China and India are expected to be the fastest growing automation and control system market in pharmaceutical and biotech industry in Asia-Pacific region. Some of the key driving forces for automation and control system market in pharmaceutical and biotech industry in emerging countries are increasing R&D investment, large pool of patients and rising government funding. 

In recent times there is increased use of automation and control system in pharmaceutical and biotech industry due to increasing growth of biosimilars. Rise in generic drugs, increase in prevalence of chronic diseases, increasing need of productivity of pharmaceutical drugs and rise in investment by biotechnology market for new drugs are some of the key factors driving the growth for global automation and control system market in pharmaceutical and biotech industry. In addition, increasing healthcare awareness is also fuelling the growth of global automation and control system market in pharmaceutical and biotech industry. However, absence of skilled workforce and different standards adopted by different equipment manufacturers are some of the major factors restraining the growth for the global automation and control system market in pharmaceutical and biotech industry. 

Increasing R&D investment and outsourcing of pharmaceutical companies would lead to growth in automation and control system market in pharmaceutical and biotech industry in Asia. In addition, cloud based technology would develop opportunity for the market.  However, high cost involved could lead a challenge for global automation and control system market in pharmaceutical and biotech industry. Some of the trends for the global automation and control system market in pharmaceutical and biotech industry are steady shift from batch manufacturing to continuous manufacturing and single use technology in manufacturing. Some of the major companies operating in the global automation and control system market in pharmaceutical and biotech industry are Siemens AG, General Electric, M+W Group and Honeywell International.

Key points covered in the report

  • Report segments the market on the basis of types, application, products, technology, etc (as applicable)
  • The report covers geographic segmentation

    • North America
    • Europe
    • Asia
    • RoW
  • The report provides the market size and forecast for the different segments and geographies for the period of 2010 to 2020
  • The report provides company profiles of some of the leading companies operating in the market
  • The report also provides porters five forces analysis of the market.

Automation control systems are used in the pharmaceutical and biotech industry as a standardized, and reliable production system. Automation is highly demanded for its positive attributes such as waste reduction, smart monitoring, effortless packaging, and enhanced speed of production. Escalating demand for standardized and dependable products at inexpensive cost is creating white spaces of growth in the market. Energy efficiency and efficacy are the other attributes of an automated system that give them prominence in the pharmaceutical industry. An increase in the growth of biosimilar has enhanced the adoption rate of these control systems. Growth in investments in the biotechnology sector and increasing preference for generic drugs are also inflating the growth opportunities of the automation systems.

 North America holds a leading position in the global market owing to growing investments in the market. Asia along with Europe is expected to generate lucrative growth prospects  for the manufcaturers. India and China have emerged as the fastest-growing markets in the pharmaceutical and biotech industry.

Prominent players have increased their investments in research and development activities in the pharmaceutical and biotech sector to gain a competitive edge in the market. Major players profiled in the global automation control system market are Honeywell International, General Electric, Siemens AG, and M+W Group.

Automation Control System Market

Back To Top